• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测宫颈癌复发和生存的双向递归神经网络方法

Bidirectional recurrent neural network approach for predicting cervical cancer recurrence and survival.

作者信息

Geeitha S, Prabha K P Rama, Cho Jaehyuk, Easwaramoorthy Sathishkumar Veerappampalayam

机构信息

Department of Information Technology, M. Kumarasamy College of Engineering, Thalavapalayam, Karur, Tamil Nadu, India.

School of Computer Science and Engineering, Vellore Institute of Technology, Chennai, Tamil Nadu, India.

出版信息

Sci Rep. 2024 Dec 30;14(1):31641. doi: 10.1038/s41598-024-80472-5.

DOI:10.1038/s41598-024-80472-5
PMID:39738223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11685496/
Abstract

Cervical cancer is a deadly disease in women globally. There is a greater chance of getting rid of cervical cancer in case of earliest diagnosis. But for some patients, there is a chance of recurrence. The chances of treating the Recurrence of cervical carcinoma arelimited. The main objective of a research is to find the key features that will predict the cervical cancer recurrence and survival rates accurately by utilizing a neural network that is bidirectionally recurrent. The goal is to reduce risk factors of cervical cancer recurrence by identifying genes with positive coefficients and targeting them for preventive interventions. First step is identification of risk factors for cervical carcinoma recurrence by utilising clinical attributes. This research uses following Random forest, Logistic regression, Gradient boosting and support vector machine algorithms are applied for classification. Random forest offers the maximum precision of these four techniques at 91.2%. The second step is identifying long noncoding RNA (lnRNA) gene signatures among people with cervical carcinomaby implementingHSIC model. Intended to discover biomarkers in initial cervical carcinoma clinical data from people who experienced a distant repetition that could be connected to lnRNA gene signatures and utilized for forecasting survival rates using a bidirectional recurrent neural network(Bi-RNN). The results shows that Bi-RNN model effectively forecast the cervical cancer recurrence and survival.

摘要

宫颈癌是全球女性中的一种致命疾病。如果能最早诊断,摆脱宫颈癌的机会就更大。但对一些患者来说,存在复发的可能性。治疗宫颈癌复发的机会有限。一项研究的主要目标是通过利用双向递归神经网络,找到能够准确预测宫颈癌复发和生存率的关键特征。目标是通过识别具有正系数的基因并针对它们进行预防性干预,来降低宫颈癌复发的风险因素。第一步是利用临床属性确定宫颈癌复发的风险因素。本研究使用随机森林、逻辑回归、梯度提升和支持向量机算法进行分类。在这四种技术中,随机森林的精度最高,为91.2%。第二步是通过实施HSIC模型,在宫颈癌患者中识别长链非编码RNA(lnRNA)基因特征。旨在从经历远处复发的患者的初始宫颈癌临床数据中发现生物标志物,这些生物标志物可能与lnRNA基因特征相关,并用于使用双向递归神经网络(Bi-RNN)预测生存率。结果表明,Bi-RNN模型有效地预测了宫颈癌的复发和生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/b69dbbbd1907/41598_2024_80472_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/f6e88eee6761/41598_2024_80472_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/57b0e5e5fba6/41598_2024_80472_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/48dbdcc6cb63/41598_2024_80472_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/f256f7aa217b/41598_2024_80472_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/e1eb6a9d2538/41598_2024_80472_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/2aa674bcd26a/41598_2024_80472_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/15aeb20f32cc/41598_2024_80472_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/b3ea0e41a2a8/41598_2024_80472_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/e2f63282ba7f/41598_2024_80472_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/b69dbbbd1907/41598_2024_80472_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/f6e88eee6761/41598_2024_80472_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/57b0e5e5fba6/41598_2024_80472_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/48dbdcc6cb63/41598_2024_80472_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/f256f7aa217b/41598_2024_80472_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/e1eb6a9d2538/41598_2024_80472_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/2aa674bcd26a/41598_2024_80472_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/15aeb20f32cc/41598_2024_80472_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/b3ea0e41a2a8/41598_2024_80472_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/e2f63282ba7f/41598_2024_80472_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45e/11685496/b69dbbbd1907/41598_2024_80472_Fig10_HTML.jpg

相似文献

1
Bidirectional recurrent neural network approach for predicting cervical cancer recurrence and survival.用于预测宫颈癌复发和生存的双向递归神经网络方法
Sci Rep. 2024 Dec 30;14(1):31641. doi: 10.1038/s41598-024-80472-5.
2
Integrating cat boost algorithm with triangulating feature importance to predict survival outcome in recurrent cervical cancer.将 catboost 算法与三角剖分特征重要性相结合,预测复发性宫颈癌的生存结局。
Sci Rep. 2024 Aug 27;14(1):19828. doi: 10.1038/s41598-024-67562-0.
3
Identifying Molecular Markers of Cervical Cancer Based on Competing Endogenous RNA Network Analysis.基于竞争性内源性 RNA 网络分析鉴定宫颈癌的分子标志物。
Gynecol Obstet Invest. 2019;84(4):350-359. doi: 10.1159/000493476. Epub 2019 Jan 9.
4
Screening of Significant Biomarkers Related to Prognosis of Cervical Cancer and Functional Study Based on lncRNA-associated ceRNA Regulatory Network.基于 lncRNA 相关 ceRNA 调控网络的宫颈癌预后相关显著生物标志物筛选及功能研究
Comb Chem High Throughput Screen. 2021;24(3):472-482. doi: 10.2174/1386207323999200729113028.
5
The expression and clinical significance of serum exosomal-long non-coding RNA DLEU1 in patients with cervical cancer.血清外泌体长链非编码RNA DLEU1在宫颈癌患者中的表达及临床意义
Ann Med. 2025 Dec;57(1):2442537. doi: 10.1080/07853890.2024.2442537. Epub 2024 Dec 17.
6
RETRACTED: Development of gene panel for predicting recurrence in early-stage cervical cancer patients.撤回:用于预测早期宫颈癌患者复发的基因检测板的开发。
Environ Toxicol. 2025 May;40(5):E44-E58. doi: 10.1002/tox.24270. Epub 2024 Apr 2.
7
The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.高危型人乳头瘤病毒相关长非编码 RNA 在宫颈鳞癌预后中的作用。
DNA Cell Biol. 2020 Apr;39(4):645-653. doi: 10.1089/dna.2019.5167. Epub 2020 Feb 11.
8
High lncRNA H19 expression as prognostic indicator: data mining in female cancers and polling analysis in non-female cancers.高lncRNA H19表达作为预后指标:女性癌症中的数据挖掘及非女性癌症中的民意调查分析
Oncotarget. 2017 Jan 3;8(1):1655-1667. doi: 10.18632/oncotarget.13768.
9
A Model for Predicting Cervical Cancer Using Machine Learning Algorithms.基于机器学习算法的宫颈癌预测模型。
Sensors (Basel). 2022 May 29;22(11):4132. doi: 10.3390/s22114132.
10
Bidirectional deep neural networks to integrate RNA and DNA data for predicting outcome for patients with hepatocellular carcinoma.双向深度神经网络整合 RNA 和 DNA 数据以预测肝细胞癌患者的预后。
Future Oncol. 2021 Nov;17(33):4481-4495. doi: 10.2217/fon-2021-0659. Epub 2021 Aug 10.

引用本文的文献

1
Integrating Clinical and Transcriptomic Profiles Associated with Vitamin D to Enhance Disease-Free Survival in Cervical Cancer Recurrence Using the CatBoost Algorithm.整合与维生素D相关的临床和转录组学特征,使用CatBoost算法提高宫颈癌复发患者的无病生存率。
Diagnostics (Basel). 2025 Jun 21;15(13):1579. doi: 10.3390/diagnostics15131579.
2
Harnessing Machine Learning, a Subset of Artificial Intelligence, for Early Detection and Diagnosis of Type 1 Diabetes: A Systematic Review.利用机器学习(人工智能的一个子集)进行1型糖尿病的早期检测与诊断:一项系统评价
Int J Mol Sci. 2025 Apr 22;26(9):3935. doi: 10.3390/ijms26093935.

本文引用的文献

1
Approaches to prevention of gynecological malignancies.妇科恶性肿瘤的预防方法。
BMC Womens Health. 2024 Apr 23;24(1):254. doi: 10.1186/s12905-024-03100-4.
2
Pharmacotherapy for the treatment of recurrent cervical cancer: an update of the literature.复发性宫颈癌的药物治疗:文献更新。
Expert Opin Pharmacother. 2024 Jan-Apr;25(1):55-65. doi: 10.1080/14656566.2023.2298329. Epub 2024 Feb 1.
3
HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of vaccination.
子宫切除术后高级别宫颈上皮内瘤变和早期宫颈癌相关 HPV 病变:关注疫苗接种的潜在作用。
Tumori. 2024 Apr;110(2):139-145. doi: 10.1177/03008916231208344. Epub 2023 Nov 17.
4
Elevated risk of cervical cancer in elderly women with incident ulcerative colitis in South Korea.韩国患有溃疡性结肠炎的老年女性患宫颈癌的风险增加。
Sci Rep. 2023 May 23;13(1):8323. doi: 10.1038/s41598-023-33476-6.
5
Prediction and Detection of Cervical Malignancy Using Machine Learning Models.基于机器学习模型预测和检测宫颈癌。
Asian Pac J Cancer Prev. 2023 Apr 1;24(4):1419-1433. doi: 10.31557/APJCP.2023.24.4.1419.
6
Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTIlity Sparing Surgery retrospective multicenter study.分析宫颈癌患者在保留生育功能治疗后的复发风险因素:保留生育力手术回顾性多中心研究。
Am J Obstet Gynecol. 2023 Apr;228(4):443.e1-443.e10. doi: 10.1016/j.ajog.2022.11.1295. Epub 2022 Nov 23.
7
Gene signature of mA RNA regulators in diagnosis, prognosis, treatment, and immune microenvironment for cervical cancer.mRNA 调节剂的基因特征在宫颈癌的诊断、预后、治疗和免疫微环境中的作用。
Sci Rep. 2022 Oct 21;12(1):17667. doi: 10.1038/s41598-022-22211-2.
8
Cervical cancer prognosis and related risk factors for patients with cervical cancer: a long-term retrospective cohort study.宫颈癌预后及相关风险因素分析:一项长期回顾性队列研究。
Sci Rep. 2022 Aug 17;12(1):13994. doi: 10.1038/s41598-022-17733-8.
9
Long-read sequencing unveils high-resolution HPV integration and its oncogenic progression in cervical cancer.长读测序揭示了宫颈癌中 HPV 整合的高分辨率及其致癌进展。
Nat Commun. 2022 May 10;13(1):2563. doi: 10.1038/s41467-022-30190-1.
10
Identifying Molecular Changes in Early Cervical Cancer Samples of Patients That Developed Metastasis.识别发生转移的患者早期宫颈癌样本中的分子变化。
Front Oncol. 2022 Jan 11;11:715077. doi: 10.3389/fonc.2021.715077. eCollection 2021.